European shares were unchanged on Friday, as losses in heavyweight healthcare shares were countered by an advance in oil and ...

In addition to obesity, modifiable risk factors include a low-quality diet (such as high consumption of processed meats, ...

A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector.

GlaxoSmithKline LLC (GSK) plans to lay off 150 Cambridge workers. The layoffs come months after GSK said it had planned to ...

Oncologic Drugs Advisory Committee (ODAC) voted against the overall benefit/risk profile at the proposed dosage of GSK plc’s ...

GSK PLC closed 19.70% below its 52-week high of £16.79, which the company achieved on September 9th.

In a surprise, a FDA advisory panel voted that risks tied to a GSK blood cancer drug called Blenrep outweighed the benefits ...

Oncologic Drugs Advisory Committee has voted against two proposed combination regimens containing GSK’s Blenrep (belantamab ...

Despite the setback with the Oncologic Drugs Advisory Committee vote, GSK emphasizes the unmet need in multiple myeloma and ...

GSK was trying to revive a product pulled from US markets in 2022. Its shares fell 4.6 per cent, or 65p, to 1348p.

Google's new Gemini Embedding model now leads the MTEB benchmark. But it is facing fierce competition from closed and open source rivals.